TNFα blocker-induced thrombocytopenia [5]

Rheumatology

Volumn 45, Issue 10, 2006, Pages 1313-1314

  Pathare, S K ^a   Heycock, C ^a   Hamilton, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; CASE REPORT; DISEASE CONTROL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LEUKOPENIA; LUNG INFECTION; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT FAILURE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; MIDDLE AGED;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; THROMBOCYTOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749599192     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel204     Document Type: Letter

References (9)

1. Keystone E. Safety of biologic therapies - an update. J Rheumatol 2005;32:8-12.
2. Cush JJ. Safety of new biologic therapies in rheumatoid arthritis. Bullet Rheum Dis 2003-04;52.
3. de Ryke L, Baten D, Kruithof E et al. Infliximab, but not etanercept, induces IgM anti-double stranded DNA autoantibodies as main antinuclear activity: Biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 2005;52:2192-201.
4. Cush JJ, Spiera R. Etanercept update in "Dear Doctor" letter. Hotline. American College of Rheumatology; November 2000. http://www.rheumatology.org/research/hotline/1200etanercept.html.
5. Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Int Med 2003;139E:238-9.
6. Menon Y, Cucurull E, Espinoza R. Pancytopenia in a patient with scleroderma treated with infliximab. Rheumatology 2003;42:1273-4.
7. Day R. Adverse reactions to TNF-alpha blockers in rheumatoid arthritis. Lancet 2002;359:540-1.
8. Keystone EC. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:427-43.
9. Hansen KE, Hilderand JP, Genovese MC et al. The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis. J Rheumatol 2004;31:1098-102.